Evidence map›Paper›PMID 21183721›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Disease allele-dependent small-molecule sensitivities in blood cells from monogenic diabetes.

Stanley Y Shaw, David M Blodgett, Maggie S Ma, Elizabeth C Westly, Paul A Clemons, Aravind Subramanian, Stuart L Schreiber

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Closing the 'phenotype gap' in precision medicine: improving what we measure to understand complex disease mechanisms.Mammalian genome : official journal of the International Mammalian Genome Society · 2019
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Genetic links between circulating cells and cardiovascular risk.Circulation. Cardiovascular genetics · 2011
    Article
  10. Organic synthesis toward small-molecule probes and drugs.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Stanley Y ShawCenter for Systems Biology, Massachusetts General Hospital, 185 Cambridge Street, Boston, MA 02114, USA. shaw.stanley@mgh.harvard.edu
David M Blodgett
Maggie S Ma
Elizabeth C Westly
Paul A Clemons
Aravind Subramanian
Stuart L Schreiber
Broad Institute · USMassachusetts General Hospital · US

Funding

SYNTHESIS OF MATERIALS WITH PHYSIOLOGICAL PROPERTIESR01GM038627 · NIGMS · YALE UNIVERSITY · PI SCHREIBER, STUART L · 1987 to 2017
$10.5M
SYNTHESIS OF MATERIALS WITH PHYSIOLOGICAL PROPERTIESR37GM038627 · NIGMS · HARVARD UNIVERSITY · PI SCHREIBER, STUART L · 1992 to 2001
$1.1M
Chemical Genetic Studies of Vascular DevelopmentK08HL077186 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI SHAW, STANLEY Y · 2004 to 2008
$649k
Howard Hughes Medical InstituteNCI NIH HHS N01 CO012400NCI NIH HHS N01-CO-12400NHLBI NIH HHS K08 HL077186NIGMS NIH HHS GM38627NIGMS NIH HHS R01 GM038627NIGMS NIH HHS R37 GM038627
6 · The paper itself

Abstract

Even as genetic studies identify alleles that influence human disease susceptibility, it remains challenging to understand their functional significance and how they contribute to disease phenotypes. Here, we describe an approach to translate discoveries from human genetics into functional and therapeutic hypotheses by relating human genetic variation to small-molecule sensitivities. We use small-molecule probes modulating a breadth of targets and processes to reveal disease allele-dependent sensitivities, using cells from multiple individuals with an extreme form of diabetes (maturity onset diabetes of the young type 1, caused by mutation in the orphan nuclear receptor HNF4α). This approach enabled the discovery of small molecules that show mechanistically revealing and therapeutically relevant interactions with HNF4α in both lymphoblasts and pancreatic β-cells, including compounds that physically interact with HNF4α. Compounds including US Food and Drug Administration-approved drugs were identified that favorably modulate a critical disease phenotype, insulin secretion from β-cells. This method may suggest therapeutic hypotheses for other nonblood disorders.

Indexed as

Adenosine TriphosphateAllelesAnimalsCombinatorial Chemistry TechniquesDiabetes Mellitus, Type 1Genetic VariationGlucoseHepatocyte Nuclear Factor 4HumansInsulinInsulin-Secreting CellsMiceModels, GeneticMutationPedigreeAdenosine TriphosphateGlucoseHepatocyte Nuclear Factor 4HNF4A protein, humanInsulin

Identifiers

PMID21183721
PMCPMC3021060
OpenAlexW2124993955

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.